Him K Shrestha is an expert in Biochemistry at St. Jude Children's Research Hospital (United States). Him K Shrestha has authored 30 publications, the most recent in 2026. SLR score: 93 (community average: 125). How the SLR is computed.

LeadR Profile

Him K Shrestha St. Jude Children's Research Hospital United States
93 ScienceLeadR Reputation 93
Network Map

Biochemistry

Subspecialties: Oncology - Neurology - Genetics

Full career – Last 3 years

Main Topics

Publications and Clinical Studies

Publications – Clinical Studies

Profile data updated on

Organizations

Career arc: 2018 - 2026

Source: PubMed

Oak Ridge National Laboratory

Publications Synthesis

Sources: PubMed, OpenAlex

Number : 30

Citations

Citations: 287 1st author: 7 Last author: 0 Unique author: 0


Best Journals

Breakdown by type

Click a legend label to hide or show it in the chart.

Latest Publications

5 most recent indexed articles

Source: Pubmed

Title Journal Year Citations
Longitudinal Proteomics Analysis of Cerebrospinal Fluid in Survivors of Childhood Acute Lymphoblastic Leukemia.
PMID 42056117 — cancer survivors, precursor cell lymphoblastic leukemia-lymphoma, neoplasms, leukemia, drug therapy, proteomics, therapeutics, proteome, chemotherapy
Sci Data20260
Pan-neurodegeneration proteomics reveals disease subtypes and molecular signatures.
PMID 41875888 — dementia, supranuclear palsy, progressive, pathology, dementia, vascular, cell biology, proteomics, protein processing, post-translational, proteome, frontotemporal lobar degeneration, neurodegenerative diseases
Cell Top journal20260
Cell type-resolved proteomics reveals intra- and intercellular signaling in Alzheimer's disease.
PMID 41676658 — microglia, cells, astrocytes, alzheimer disease, brain, proteomics, oligodendrocyte precursor cells
bioRxiv20260
Single Plaque Proteomics Reveals the Composition and Dynamics of the Amyloid Microenvironment in Alzheimer's Disease.
PMID 41676572 — cells, plaque, amyloid, alzheimer disease, brain, proteomics, amyloid
bioRxiv20260
Proteomic landscape of Alzheimer's disease: emerging technologies, advances and insights (2021 - 2025).
PMID 40660303 — cells, alzheimer disease, biomarkers, proteomics, amyloid, proteome, tissues
Mol Neurodegener20250

LeadR Networks

Main global connection map